Loading…
Normovolemic hemodilution with Hb vesicle solution attenuates hypoxia in ischemic hamster flap tissue
1 Department of Orthopedic, Plastic, and Hand Surgery, Inselspital University Hospital, 3010 Berne, Switzerland; and 2 Advanced Research Institute for Science and Engineering, Waseda University, Tokyo 169-8555, Japan The aim of this study was to test whether oxygenation in acutely ischemic, collat...
Saved in:
Published in: | American journal of physiology. Heart and circulatory physiology 2003-05, Vol.284 (5), p.H1702-H1709 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | 1 Department of Orthopedic, Plastic, and Hand
Surgery, Inselspital University Hospital, 3010 Berne,
Switzerland; and 2 Advanced Research
Institute for Science and Engineering, Waseda University, Tokyo
169-8555, Japan
The aim of this study
was to test whether oxygenation in acutely ischemic,
collateralized tissue may be improved by normovolemic hemodilution with
a solution containing liposome-encapsulated human Hb (HbV). A skin flap
model in anesthetized hamsters was used, which consisted of two parts
receiving either anatomic or collateral perfusion. Microhemodynamics
were investigated with intravital microscopy. Partial tissue oxygen
tension was measured with a Clark-type microprobe. Hemodilution was
obtained by exchanging 50% of the total blood volume with HbV
suspended in 8% human serum albumin (HSA8) or 6% Dextran 70 (Dx70).
The size of the vesicles was 276 nm, the P 50 was 22 mmHg,
and the Hb concentration of the solutions was 7.5 g/dl. Colloid
osmotic pressure and viscosity were 49.9 mmHg and 8.7 cP for HbV-Dx70
and 40.0 mmHg and 2.9 cP for HbV-HSA8, respectively. Hemodilution with
HbV-Dx70 led to an increase in microvascular blood flow in the
ischemic microvessels to maximally 158% (median,
P |
---|---|
ISSN: | 0363-6135 1522-1539 |
DOI: | 10.1152/ajpheart.00821.2002 |